Showing results (61-70 of 170) with videos related to
Sort By:
Pageof 17
Journal of Clinical Psychopharmacology|September 15, 2005
Drug-induced agranulocytosis: impact of different fcgamma receptor polymorphisms?Igor Mosyagin, Ingolf Cascorbi, Rainer Schaub, et al.Pharmacogenetics|October 3, 2002
Lack of association between arylamine N-acetyltransferase 2 (NAT2) polymorphism and systemic lupus erythematosusPetra Zschieschang, Falk Hiepe, Erika Gromnica-Ihle, et al.Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|July 27, 2013
Implication of arylamine N-acetyltransferase (NAT2) polymorphism on levels of tumour markers CEA, AFP, CA 125, CA 19.9, and CA 15.3Necat Yilmaz A Sukru Aynacioglu Binnur Erbagci Ingolf Cascorbi Ivar RootsJournal of Clinical Psychopharmacology|November 13, 2004
Impact of myeloperoxidase and NADPH-oxidase polymorphisms in drug-induced agranulocytosisIgor Mosyagin, Michael Dettling, Ivar Roots, et al.Basic & Clinical Pharmacology & Toxicology|October 12, 2007
Educating European (junior) doctors for safe prescribingSimon R J Maxwell, Ingolf Cascorbi, Michael Orme, et al.Liver International : Official Journal of the International Association for the Study of the Liver|April 6, 2006
Multidrug resistance 1 genotype and disposition of budesonide in early primary biliary cirrhosisKarin Dilger, Ingolf Cascorbi, Frank Grünhage, et al.Molecular and Cellular Neurosciences|April 18, 2017
Crosstalk control and limits of physiological c-Jun N-terminal kinase activity for cell viability and neurite stability in differentiated PC12 cellsVicki Waetzig, Milana Belzer, Wiebke Haeusgen, et al.Pharmacogenetics and Genomics|November 8, 2005
Identification and functional analysis of genetic variants of the human beta-glucuronidase in a German population sampleMatthias Gratz, Christiane Kunert-Keil, Ulrich John, et al.Carcinogenesis|January 1, 2003
CYP1A1 and GSTM1 genotypes affect benzo[a]pyrene DNA adducts in smokers' lung: comparison with aromatic/hydrophobic adduct formationKroum Alexandrov, Ingolf Cascorbi, Margarita Rojas, et al.Pharmacogenetics and Genomics|March 13, 2008
Influence of genetic polymorphisms on intestinal expression and rifampicin-type induction of ABCC2 and on bioavailability of talinololSierk Haenisch, Karen May, Danilo Wegner, et al.Pageof 17